Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy

Author： Gallwitz Baptist  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.6, 2011-06, pp. : 723-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Inhibitors of STAT3 for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 26, 2011-09 ,pp. : 4012-4018

Bentham Science Publishers

Access to resources Recommend Favorite

Modeling Assisted In Silico Design of Ligand Molecule for DPP IV in Type II Diabetes Mellitus

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 8, 2012-10 ,pp. : 764-766

Bentham Science Publishers

Access to resources Recommend Favorite

Progress Towards Therapeutic Small Molecule MEK Inhibitors for Use in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 215-229

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 84-125

Bentham Science Publishers

Access to resources Recommend Favorite

Development for Anticancer Therapy: Small-Molecule Inhibitors Targeting Protein Kinase B

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-01 ,pp. : 1272-1294

Bentham Science Publishers

Access to resources Recommend Favorite